J&J in Risperal Settlement

August 2, 2012, 3:30 am by Wall Street Journal

J&J said it reached an agreement in principle with the Justice Department and some states on settling investigations into marketing practices, including the illegal promotion of the antipsychotic Risperdal.

Read the full article

More from Wall Street Journal

Older, Yes, but Sharp as a Tack
Wall Street Journal : May 24, 2013, 7:59 am
A group of 42 people over the age of 80 have been identified by Northwestern University researchers as having excellent cognitive function and memory capability typical of those decades younger.

Turkey Moves to Curb Alcohol Sales
Wall Street Journal : May 24, 2013, 7:41 am
Turkey moved to curb alcohol sales and restrict advertisements in a move likely to deepen outrage among secular Turks who accuse the government of having an Islamist agenda.

Doubt Cast on Potential Alzheimer's Treatment
Wall Street Journal : May 23, 2013, 8:39 am
Four research teams have been unable to replicate a finding of a 2012 study that showed how an existing cancer drug reversed signs of Alzheimer's disease in the brains of mice.

Electronic Health Data Gaining Favor, HHS Says
Wall Street Journal : May 22, 2013, 12:09 pm
More than half of U.S. doctors have switched to electronic health records and are using them to manage patients' basic medical information and prescriptions.

FDA Panel Backs Merck Insomnia Drug
Wall Street Journal : May 22, 2013, 9:31 am
A federal advisory panel on Wednesday partly endorsed a proposed sleep drug from Merck, saying the product was effective and acceptably safe at lower starting doses.